PHASEBIO PHARMACEUTICALS INC's ticker is and the CUSIP is 717224959. A total of 2 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,000 | -87.5% | 1,400 | -57.6% | 0.00% | – |
| Q4 2021 | $8,000 | -78.9% | 3,300 | -68.6% | 0.00% | – |
| Q3 2021 | $38,000 | -2.6% | 10,500 | 0.0% | 0.00% | – |
| Q2 2021 | $39,000 | +875.0% | 10,500 | +74900.0% | 0.00% | – |
| Q1 2021 | $4,000 | +300.0% | 14 | +366.7% | 0.00% | – |
| Q4 2020 | $1,000 | -94.4% | 3 | -92.5% | 0.00% | – |
| Q2 2020 | $18,000 | – | 40 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 100 | $0 | 0.00% |